Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000475844 | SCV000562839 | benign | Brugada syndrome 4 | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001612946 | SCV001835837 | benign | not provided | 2018-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411192 | SCV002720981 | likely benign | Cardiovascular phenotype | 2018-06-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001699433 | SCV001920660 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001612946 | SCV001965659 | likely benign | not provided | no assertion criteria provided | clinical testing |